Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration

Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine

Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer

First Department of Internal Medicine (Division of Hematology), Tokyo Medical University

東京大学医科学研究所附属病院 血液腫瘍内科

Department Of Hematology/oncology The Institute Of Medical Science The University Of Tokyo

Department Of Hematology/oncology

Department of Internal Medicine, School of Medicine, Keio University

Institute of Medical Science, University of Tokyo

Institute of Medical Science, University of Tokyo

Department of Internal Medicine, Keio University

Department Of Hematology/oncology The Institute Of Medical Science The University Of Tokyo

東京大学医科学研究所 血液腫瘍内科

Department Of Pediatric Hematology/oncology The Institute Of Medical Science The University Of Tokyo

国立がんセンター中央病院 血液内科

Third Department Of Internal Medicine Hamamatsu University School Of Medicine

東北大学病院 血液･免疫科

The Institute of Medical Science, The University of Tokyo

Department Of Hematology And Molecular Medicine Nagasaki University Graduate School Of Biomedical Sc

Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University S

National Hospital Organization Nagoya Medical Center

Institute Of Medical Science University Of Tokyo

Department Of Pediatric Hematology/oncology The Institute Of Medical Science The University Of Tokyo

Division Of Hematology Department Of Internal Medicine Juntendo University School Of Medicine

Department Of Hematology Saitama Medical University

Department of Hematology, Tokyo Women's Medical College

First Department of Internal Medicine, Saitama Medical School

Division of Hematology and Rheumatology, Tokai University School of Medicine

Department of Clinical Immunology and Hematology, Kobe City General Hospital

Japanese Red Cross Saitama Ina Blood Center

First Department of Internal Medicine, Saitama Medical School

Department Of Internal Medicine Keio University

Division Of Hematology Department Of Medicine Keio University School Of Medicine

Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine

Department Of Medicine School Of Medicine Keio University

Univ. Tokyo Tokyo Jpn

Division Of Hematology Department Of Internal Medicine Faculty Of Medicine Saitama Medical Universit

First Department Of Internal Medicine Saitama Medical School

Department Of Hematology And Oncology Institute Of Medical Science University Of Tokyo

Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi

Department Of Hematology Saitama Medical Center Saitama Medical University

Department Of Internal Medicine Keio University School Of Medicine Tokyo

First Deparmtne Of Internal Medicine Tokyo Medical University

The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And

Department Of Earth Science Hokkaido University Of Education At Kushiro

Department Of Haematology Atomic Bomb Disease Institute Nafasaki University School Of Medicine

Department Of Internal Medicine Hamamatsu University School Of Medicine

Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University S

Department Of Clinical Immunology And Hematology Kobe City General Hospital

Department Of Internal Hematology Tokyo Women's Medical College

Department Of Hematology Tokyo Women's Mdical University

Univ. Tokyo Tokyo Jpn

First Department Of Internal Medicine Saitama Medical School

The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And

Department Of Biophysics And Biochemistry Graduate School Of Science University Of Tokyo

The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And